Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec 22;18(1):490.
doi: 10.1186/s12967-020-02669-2.

COVID-19 biomarkers for severity mapped to polycystic ovary syndrome

Abu Saleh Md Moin  1 , Thozhukat Sathyapalan  2 , Stephen L Atkin #  3 , Alexandra E Butler #  4
Affiliations
Comment

COVID-19 biomarkers for severity mapped to polycystic ovary syndrome

Abu Saleh Md Moin et al. J Transl Med. .

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

No authors have any conflict of interest or competing interests to declare.

Comment on

  • Large-scale Multi-omic Analysis of COVID-19 Severity.
    Overmyer KA, Shishkova E, Miller IJ, Balnis J, Bernstein MN, Peters-Clarke TM, Meyer JG, Quan Q, Muehlbauer LK, Trujillo EA, He Y, Chopra A, Chieng HC, Tiwari A, Judson MA, Paulson B, Brademan DR, Zhu Y, Serrano LR, Linke V, Drake LA, Adam AP, Schwartz BS, Singer HA, Swanson S, Mosher DF, Stewart R, Coon JJ, Jaitovich A. Overmyer KA, et al. medRxiv [Preprint]. 2020 Jul 19:2020.07.17.20156513. doi: 10.1101/2020.07.17.20156513. medRxiv. 2020. Update in: Cell Syst. 2021 Jan 20;12(1):23-40.e7. doi: 10.1016/j.cels.2020.10.003. PMID: 32743614 Free PMC article. Updated. Preprint.

References

    1. Overmyer KA, Shishkova E, Miller IJ, Balnis J, Bernstein MN, Peters-Clarke TM, et al. Large-Scale Multi-omic Analysis of COVID-19 Severity. Cell Syst. 2020 doi: 10.1016/j.cels.2020.10.003. - DOI - PMC - PubMed
    1. Moin ASM, Sathyapalan T, Atkin SL, Butler AE. Renin-Angiotensin System Overactivation in Polycystic Ovary Syndrome, a Risk for SARS-CoV-2 Infection? Metabol Open. 2020;7:100052. doi: 10.1016/j.metop.2020.100052. - DOI - PMC - PubMed
    1. Mak W, Dokras A. Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis. Semin Thromb Hemost. 2009;35(7):613–620. doi: 10.1055/s-0029-1242715. - DOI - PubMed
    1. Yildiz BO, Haznedaroğlu IC, Kirazli S, Bayraktar M. Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state. J Clin Endocrinol Metabol. 2002;87(8):3871–3875. doi: 10.1210/jcem.87.8.8716. - DOI - PubMed
    1. Oral B, Mermi B, Dilek M, Alanoğlu G, Sütçü R. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome. Gynecol Endocrinol. 2009;25(2):110–116. doi: 10.1080/09513590802549874. - DOI - PubMed

LinkOut - more resources